Mi Yan

1.0k total citations · 1 hit paper
21 papers, 866 citations indexed

About

Mi Yan is a scholar working on Molecular Biology, Organic Chemistry and Ophthalmology. According to data from OpenAlex, Mi Yan has authored 21 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Ophthalmology. Recurrent topics in Mi Yan's work include Retinal Diseases and Treatments (5 papers), Click Chemistry and Applications (4 papers) and Glaucoma and retinal disorders (4 papers). Mi Yan is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Click Chemistry and Applications (4 papers) and Glaucoma and retinal disorders (4 papers). Mi Yan collaborates with scholars based in China, United States and Australia. Mi Yan's co-authors include Yichao Wan, Zilong Tang, Yuanhua Li, Catherine P. Kirschke, Liping Huang, Wenjin Zhu, Ming Zhang, Hongmei Luo, Ming Zhang and Dechao Yu and has published in prestigious journals such as Ophthalmology, Experimental Cell Research and Medicine.

In The Last Decade

Mi Yan

21 papers receiving 853 citations

Hit Papers

Indole: A privileged scaffold for the design of anti-canc... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Yan China 12 393 296 166 126 65 21 866
Hongyan Du United States 20 104 0.3× 537 1.8× 16 0.1× 16 0.1× 73 1.1× 39 899
Minsoo Song South Korea 18 404 1.0× 347 1.2× 12 0.1× 42 0.3× 60 0.9× 33 823
Ian L. Scott United States 14 396 1.0× 254 0.9× 49 0.3× 49 0.4× 52 0.8× 23 762
Camila Maria Longo Machado Brazil 14 116 0.3× 257 0.9× 4 0.0× 78 0.6× 145 2.2× 28 742
Du‐Shieng Chien United States 15 48 0.1× 314 1.1× 158 1.0× 91 0.7× 148 2.3× 22 783
Zhongwei Zhang China 14 90 0.2× 288 1.0× 7 0.0× 11 0.1× 193 3.0× 39 602
Caterina Camodeca Italy 15 103 0.3× 264 0.9× 11 0.1× 37 0.3× 241 3.7× 30 603
Wayne D. Klohs United States 16 135 0.3× 456 1.5× 7 0.0× 49 0.4× 249 3.8× 33 728
Martin Wurm Austria 12 45 0.1× 364 1.2× 24 0.1× 82 0.7× 233 3.6× 20 861
Eunhye Oh South Korea 16 26 0.1× 363 1.2× 21 0.1× 25 0.2× 275 4.2× 31 703

Countries citing papers authored by Mi Yan

Since Specialization
Citations

This map shows the geographic impact of Mi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Yan more than expected).

Fields of papers citing papers by Mi Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Yan. The network helps show where Mi Yan may publish in the future.

Co-authorship network of co-authors of Mi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Yan. A scholar is included among the top collaborators of Mi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Yan. Mi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Zhichao, Mi Yan, Ting Yao, et al.. (2024). Machine learning‐derived prognostic signature for progression‐free survival in non‐metastatic nasopharyngeal carcinoma. Head & Neck. 47(1). 112–128. 3 indexed citations
2.
Yan, Mi, Linlin Xu, Yinhu Wang, et al.. (2020). Opportunities and challenges of using five‐membered ring compounds as promising antitubercular agents. Drug Development Research. 81(4). 402–418. 28 indexed citations
3.
Wan, Yichao, et al.. (2019). Indole: A privileged scaffold for the design of anti-cancer agents. European Journal of Medicinal Chemistry. 183. 111691–111691. 408 indexed citations breakdown →
4.
Yan, Mi, Linlin Xu, Yinhu Wang, et al.. (2019). Synthesis and antibacterial activity of 11,12-cyclic carbonate 4″-O-aralkylacetylhydrazineacyl azithromycin derivatives. Bioorganic Chemistry. 94. 103475–103475. 5 indexed citations
5.
Li, Juan, Mi Yan, Jing Wu, et al.. (2019). Activity and mechanism of flavokawain A in inhibiting permeability‑glycoprotein expression in paclitaxel resistance of lung cancer. Oncology Letters. 19(1). 379–387. 16 indexed citations
6.
Chen, Hai‐Sheng, Mi Yan, Jing Shi, et al.. (2019). Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients. Medicine. 98(43). e17559–e17559. 3 indexed citations
7.
Wu, Jing, Chao Sun, Ruoyi Wang, et al.. (2018). Cardioprotective effect of paeonol against epirubicin-induced heart injury via regulating miR-1 and PI3K/AKT pathway. Chemico-Biological Interactions. 286. 17–25. 51 indexed citations
8.
Wan, Yichao, et al.. (2018). Selective MMP-13 Inhibitors: Promising Agents for the Therapy of Osteoarthritis. Current Medicinal Chemistry. 27(22). 3753–3769. 40 indexed citations
9.
Li, Jia, et al.. (2017). Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides. Bioorganic & Medicinal Chemistry Letters. 27(16). 3693–3697. 6 indexed citations
10.
Yan, Mi, et al.. (2016). Synthesis and antibacterial activity of novel 3- O -descladinosylazithromycin derivatives. European Journal of Medicinal Chemistry. 127. 874–884. 8 indexed citations
11.
Yan, Mi, Xiaodong Ma, Xin Li, et al.. (2015). Synthesis and antibacterial activity of 4″-O-(trans-β-arylacrylamido)carbamoyl azithromycin analogs. European Journal of Medicinal Chemistry. 103. 506–515. 7 indexed citations
12.
Wang, Yi, et al.. (2015). Synthesis and Antibacterial Activity of Novel 4‐Bromo‐1H‐Indazole Derivatives as FtsZ Inhibitors. Archiv der Pharmazie. 348(4). 266–274. 11 indexed citations
13.
Chan, Kwok Hung, Mi Yan, Kelvin Kai‐Wang To, et al.. (2013). Use of the human colorectal adenocarcinoma (Caco‐2) cell line for isolating respiratory viruses from nasopharyngeal aspirates. Journal of Medical Virology. 85(5). 874–879. 5 indexed citations
14.
15.
Huang, Liping, Mi Yan, & Catherine P. Kirschke. (2010). Over-expression of ZnT7 increases insulin synthesis and secretion in pancreatic β-cells by promoting insulin gene transcription. Experimental Cell Research. 316(16). 2630–2643. 45 indexed citations
16.
Zhang, Ming, et al.. (2010). A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration. Ophthalmology. 118(4). 672–678. 91 indexed citations
17.
Zhang, Ming, Junjun Zhang, Mi Yan, et al.. (2008). Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys.. PubMed. 14. 37–49. 80 indexed citations
18.
Zhang, Ming, Mi Yan, Li Wang, et al.. (2008). [Experimental choroidal neovascularization induced by laser in the eyes of rhesus monkeys].. PubMed. 39(4). 567–9, 574. 3 indexed citations
19.
Qian, Hui, Chaoneng Ji, Shuo Zhao, et al.. (2007). Expression and characterization of HSPC129, a RNA polymerase II C-terminal domain phosphatase. Molecular and Cellular Biochemistry. 303(1-2). 183–188. 11 indexed citations
20.
Zhang, Meixia, Yang Yang, Mi Yan, & Junjun Zhang. (2005). Downregulation of vascular endothelial growth factor and integrinβ3 by endostatin in a mouse model of retinal neovascularization. Experimental Eye Research. 82(1). 74–80. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026